Skip to content

Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02756156
Enrollment
30
Registered
2016-04-29
Start date
2016-04-30
Completion date
2016-08-31
Last updated
2016-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Humerus Fracture

Keywords

interscalene, infraclavicular, humerus surgery

Brief summary

Combining interscalene block with infraclavicular block for humerus surgery provides a unique surgical anaesthesia and postoperative analgesia.

Detailed description

Interscalene block provides effective surgical anaesthesia for shoulder and proximal arm surgery. However, sometimes it can be inadequate for distal arm surgery. Combining infraclavicular block with interscalene block may provide a successful surgical anaesthesia for humerus surgery.

Interventions

None listed

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients accepting peripheral nerve block technique for humerus surgery * Unilateral orthopedic humerus surgery * 18 years of age or older

Exclusion criteria

* Patients refused peripheral nerve block * Non-cooperate patients * Neuropathy of any etiology in the affected extremity

Design outcomes

Primary

MeasureTime frameDescription
Success rate of block10 min.- 20 min.A complete sensory loss in distribution of the radial, median, ulnar, musculocutaneous and medial cutaneous nerves of the arm

Secondary

MeasureTime frame
Technique duration5 min.
Number of participants with treatment-related adverse events as assessed by CTCAE v4.024 hours
Complication rate24 hours

Contacts

Primary ContactBora Bilal, Asist. Prof.
bilalbora@yahoo.com+903442803245

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026